These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 24595)

  • 1. Decrease of peripheral resistance after acute intravenous application of a new beta-receptor blocking agents, bufuralol HCl.
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G; Korn A
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):54-8. PubMed ID: 24595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol.
    Magometschnigg D; Bonelli J; Kaik G
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):429-32. PubMed ID: 41815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic changes in hypertensive patients at rest and during physical exercise before and after acute i.v. administration of bufuralol-HCl or propranolol.
    Magometschnigg D; Bonelli J; Kaik G; Rameis H
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):334-40. PubMed ID: 39899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Human pharmacological studies on the hemodynamic effects of a new beta-adrenergic antagonist (bufuralol-Hcl).
    Magometschnigg D; Korn A; Bonelli J; Hitzenberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R95. PubMed ID: 238156
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute hemodynamic effects of bufuralol: a beta-adrenoceptor blocking drug with vasodilatory effects.
    Pfisterer M; Burckhardt D; Bühler FR; Burkart F
    J Cardiovasc Pharmacol; 1984; 6(3):417-22. PubMed ID: 6202966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
    Hamilton TC; Parkes MW
    Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An echocardiographic study of interactions between pindolol and epinephrine contained in a local anesthetic solution.
    Sugimura M; Hirota Y; Shibutani T; Niwa H; Hori T; Kim Y; Matsuura H
    Anesth Prog; 1995; 42(2):29-35. PubMed ID: 8934951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative clinical and hemodynamic investigations on two beta-receptor blocking agents (pindolol and mepindolol) in normal subjects.
    Wink K
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):126-30. PubMed ID: 6715080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of nebivolol.
    Janssens WJ
    J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog.
    Blaber LC; Burden DT; Eigenmann R; Gerold M
    J Cardiovasc Pharmacol; 1984; 6(1):165-75. PubMed ID: 6199600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of a new beta-blocker (CI 775) on left ventricular hemodynamics at rest and during exercise (author's transl)].
    Trieb G; Sigwart U
    Herz; 1978 Aug; 3(4):276-87. PubMed ID: 31326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
    Erkinaro T; Kavasmaa T; Ylikauma L; Mäkikallio K; Haapsamo M; Acharya G; Ohtonen P; Alahuhta S; Räsänen J
    Reprod Sci; 2009 Aug; 16(8):749-57. PubMed ID: 19380903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms (author's transl)].
    Rostan A
    Schweiz Rundsch Med Prax; 1978 Jan; 67(1):27-35. PubMed ID: 23523
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of adrenergic beta-receptor blocking agents.
    Sannerstedt R
    Adv Clin Pharmacol; 1976; 11():70-8. PubMed ID: 25571
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamic effects of a new beta-adrenergic blocking agent].
    Bross W; Kustrzycki A; Olejak B; Bross T; Koltowski R; Masiak M
    Kardiol Pol; 1973; 16(3):201-12. PubMed ID: 4147242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.